A new Alzheimer’s drug has shown promise in slowing cognitive decline in Phase 3 clinical trials but concerns remain about its safety. Former MetroHealth CEO Akram Boutros is suing the hospital system and its board of trustees for violating Ohio’s Open Meetings Act--and its own bylaws--when it fired him. And Twitter has quietly stopped enforcing its COVID-19 misinformation policy. That's coming up on today's episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
